Dec. 24 at 3:29 PM
$MBIO Another L for the CEO’s belt…
On December 17, 2025, the Company and Fred Hutch entered into a Termination and Release Agreement, pursuant to which: (i) the Company and Fred Hutch agreed to terminate the CD20 License Agreement; (ii) the Company agreed to pay Fred Hutch
$730,000 as consideration for extinguishment of
approximately
$1.4 million in outstanding payables owing to Fred Hutch; and (iii) the parties agreed that, in the event that Fred Hutch, during the three-year period following execution of the Termination and Release Agreement, grants any third party a license under the CD20 patents or other intellectual property that had been licensed to the Company under the CD20 License Agreement, then Fred Hutch will pay to the Company at least 10% of all consideration
received by Fred Hutch from such third party under such licensing arrangement (with an additional obligation to negotiate in good faith for a potentially greater percentage share).” 8-K via 12/23/25
